The Effect of Gliatamin (Chonline Alphoscerate) on Depressive Mood in Type 2 Diabetes Patients

Clinical trial NCT03059069 · RECRUITING

Trial details

NCT number: NCT03059069
Sponsor: Yonsei University
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Type2 Diabetes With Depressive Mood

Start date: 2016-06-01
Primary completion: 2025-06-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.